Colite e morbo di Crohn
- Cannabidiol in inflammatory bowel diseases: a brief overview (PubMed)
- Cannabis finds its way into treatment of Crohn’s disease (PubMed)
- Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis(PubMed)
- Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis (PubMed)
- The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis (PubMed)
- Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice(PubMed)
- Cannabinoids and the gut: New developments and emerging concepts (PubMed)
- Endocannabinoids and the gastrointestinal tract (PubMed)
- Cannabinoids and gastrointestinal motility: Animal and human studies (PubMed)
- Hergenrather presents study of Crohn’s patients as a template for clinical research on Cannabis (O’Shaughnessy’s)
- Clinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? (PubMed)
- Cannabinoid actions at TRPV channels: Effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation (PubMed)
- Therapeutic potential of cannabinoid-based drugs (PubMed)
- Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease (Biochemical Pharmacology) (PubMed)